Table 1.
Family | Phenotypea | Age of Onset | Number Affected | Nucleic Acid Mutation | Amino Acid Alteration | PolyPhe-2 Score | PolyPhen-2 Conservationb |
---|---|---|---|---|---|---|---|
AUS1 | DCSMA | birth | 6 | c.320C>T | p.Ser107Leu | 0.999 | 39/40 |
AUSTRIA1 | DCSMA | birth | 5 | c.320C>T | p.Ser107Leu | 0.999 | 39/40 |
USA1 | DCSMA+UMN | birth | 4 | c.320C>T | p.Ser107Leu | 0.999 | 39/40 |
UK2 | DCSMA+UMN | birth | 1 | c.565A>T | p.Ile189Phe | 1.00 | 44/44 |
UK1 | DCSMA+UMN | birth | 6 | c.1502G>C | p.Arg501Pro | 0.98 | 34/44 |
GERMANY1 | HSP | adulthood | 4 | c.1523A>C | p.Lys508Thr | 0.912 | 32/44 |
In silico prediction of the functional consequences of the six mutations was performed with PolyPhen-2, and all six mutations were compared against the NHLBI Exome Sequencing Project Exome Variant Server for confirmation of novelty.
DCSMA+UMN indicates that UMN features were present in at least one family member.
The numerator indicates the number of species conserved for the unaltered amino acid at this location, and the denominator indicates the number of species for which the amino acid sequence is known at this location (according to PolyPhen-2 data).